Codiak Biosciences Investors

46 investors on Angel Roster list Codiak Biosciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series A and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Codiak Biosciences can appear together.

Investors listed
46
With verified email
50%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Codiak Biosciences investors

The most complete profiles first. Showing 40 of 46.

  • Alex GoldsmithVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Avak KahvejianVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Verified email available

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Ewen CameronVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Molly GibsonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Nick PlugisVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sabrina YangVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Sebastian TrousilVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Stephen BerensonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Torben Straight NissenVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Douglas ColeVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Ignacio MartinezVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more

    Verified email available

  • Jim GilbertVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Oleg NodelmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Sarah MarriottVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Scott PlatshonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Eytan Weinstein

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Geoffrey von Maltzahn

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Harry Wilcox

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Contact details available

  • Jacob Rubens

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Nathan Stebbins

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Yiqun Bai, Ph.D.

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Mark EdwardsVerified

    Private Equity Firm · United States

    Health CareRemote Work TechHospitalsCustomer Service

    Portfolio: The Riveter, AccuMED Technologies, 48forty, United Language Group and 4 more

    Verified email available

  • Michael HallVerified

    Venture Capital, Private Equity Firm · United States

    Health CareRemote Work TechHospitalsCustomer Service

    Portfolio: The Riveter, AccuMED Technologies, 48forty, United Language Group and 4 more

    Verified email available

  • William DietzVerified

    Venture Capital, Private Equity Firm · United States

    Health CareRemote Work TechHospitalsCustomer Service

    Portfolio: The Riveter, AccuMED Technologies, 48forty, United Language Group and 4 more

    Verified email available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Caroline Stout

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • John Casey

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Jonathan Kabakoff

    Corporate Venture Capital · United States

    Health CareWomen FoundedChemicalLife Science

    Portfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Noubar Afeyan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

See all 46 Codiak Biosciences investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Codiak Biosciences investors are on Angel Roster?

Angel Roster lists 46 Codiak Biosciences investors. 23 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (41), Private Equity Firms (16) and Entrepreneurship Programs (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Codiak Biosciences investors invest in?

Among those that list a stage, the most common are Series A (14), Series B (7) and Seed (1).

Where are Codiak Biosciences investors based?

Most are based in the United States (45) and the United Kingdom (1).

Which companies have Codiak Biosciences investors backed?

The most-backed portfolio companies among them are KSQ Therapeutics (29), Sana Biotechnology (29), Syros Pharmaceuticals (28), Editas Medicine (28) and Foghorn Therapeutics (23).

How do I contact Codiak Biosciences investors?

Create a free Angel Roster account to search and filter all 46, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.